SP

Shabeena Parveen

Active Director Director DIN 11250594
DIN 11250594 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shabeena Parveen

Data last updated:

Shabeena Parveen is a Director at Syraval Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11250594
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20252025Active

Board colleagues of Shabeena Parveen

NameDINCompanyDesignation
Niaz Ahmad11250593Syraval Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Syraval Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shabeena Parveen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shabeena Parveen

Shabeena Parveen currently holds 1 directorship: Syraval Pharmaceuticals Private Limited (Director, since 20 Aug 2025).

Shabeena Parveen was first appointed on 20 Aug 2025 as Director at Syraval Pharmaceuticals Private Limited.

The current boards of Shabeena Parveen's companies include Niaz Ahmad (Syraval Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available